tDCS and Aphasia Therapy in the Acute Phase After Stroke


Phase 2 Results N/A

Summary of Purpose

This study evaluates the neuromodulatory effect of combined tDCS and aphasia therapy in patients in the acute stage after stroke. Half of the participants will receive aphasia therapy and tDCS, the other half will receive aphasia therapy and sham-tDCS.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 December 2017.

2 Oct 2017 5 Sep 2017 1 Sep 2021 1 Sep 2021 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available